Patients received either conventional radiation in 25 sessions over five weeks or 16 sessions over roughly three weeks. Two years after reconstructive surgery, complication rates were statistically ...
The drug, also known as dasabuvir, was granted authorisation in the European Union in January 2015 for the treatment of chronic hepatitis C, a liver disease caused by a bloodborne virus.